Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |